Literature DB >> 25107362

Barriers and facilitators to the implementation of SPNS interventions designed to engage and retain HIV positive women of color in medical care.

Iliana A Garcia1, Arthur E Blank, Elizabeth A Eastwood, Alison Karasz.   

Abstract

The use of evidence-based strategies to increase access to medical care and improve health outcomes for people living with HIV is a major public health priority in the United States. As part of a multi-site evaluation funded under the Health Resources and Services Administration (HRSA), a process evaluation was conducted with the goal of understanding barriers and facilitators to the implementation of eleven heterogeneous interventions designed to engage and retain HIV positive women of color (WoC) in medical care. Findings identified barriers and facilitators to program implementation at five levels: (1) program; (2) team; (3) agency; (4) partner network; and (5) the larger socio-ecological context. We conclude with a series of recommendations that may be useful for the implementation of similar interventions focused on recruitment and retention of WoC in HIV medical care.

Entities:  

Mesh:

Year:  2015        PMID: 25107362     DOI: 10.1007/s10461-014-0837-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  4 in total

1.  Comparison of HIV Viral Suppression Between a Sample of Foreign-Born and U.S.-Born Women of Color in the United States.

Authors:  Amanda Nace; Glen Johnson; Elizabeth Eastwood
Journal:  J Immigr Minor Health       Date:  2021-05-11

2.  Factors associated with retention and viral suppression among a cohort of HIV+ women of color.

Authors:  Arthur E Blank; Jason Fletcher; Niko Verdecias; Iliana Garcia; Oni Blackstock; Chinazo Cunningham
Journal:  AIDS Patient Care STDS       Date:  2014-12-02       Impact factor: 5.078

3.  Barriers and Facilitators to the Implementation of a National HIV Linkage, Re-Engagement, and Retention in Care Program.

Authors:  Cathy Maulsby; Paul Sacamano; Kriti M Jain; Blessing Enobun; Meredith L Brantley; Hae-Young Kim; Morey Riordan; Melissa Werner; David R Holtgrave
Journal:  AIDS Educ Prev       Date:  2017-10

4.  Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.

Authors:  Alain H Litwin; John Jost; Katherine Wagner; Moonseong Heo; Alison Karasz; Judith Feinberg; Arthur Y Kim; Paula J Lum; Shruti H Mehta; Lynn E Taylor; Judith I Tsui; Irene Pericot-Valverde; Kimberly Page
Journal:  Contemp Clin Trials       Date:  2019-10-24       Impact factor: 2.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.